These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21255016)

  • 41. Amnestic effect of L-proline does not depend upon inhibition of brain protein synthesis.
    Cherkin A; Bennett EL; Davis JL
    Brain Res; 1981 Nov; 223(2):455-8. PubMed ID: 7197186
    [No Abstract]   [Full Text] [Related]  

  • 42. Publisher Correction: Brain-specific Crmp2 deletion leads to neuronal development deficits and behavioural impairments in mice.
    Zhang H; Kang E; Wang Y; Yang C; Yu H; Wang Q; Chen Z; Zhang C; Christian KM; Song H; Ming GL; Xu Z
    Nat Commun; 2018 Jul; 9():16229. PubMed ID: 30019698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer's Disease.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal delivery of a CRMP2-derived CBD3 adenovirus improves cognitive function and pathology in APP/PS1 transgenic mice.
    Qi B; Yang Y; Cheng Y; Sun D; Wang X; Khanna R; Ju W
    Mol Brain; 2020 Apr; 13(1):58. PubMed ID: 32272942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Tripeptide RER Mimics Secreted Amyloid Precursor Protein-Alpha in Upregulating LTP.
    Morrissey JA; Bigus E; Necarsulmer JC; Srinivasan V; Peppercorn K; O'Leary DJ; Mockett BG; Tate WP; Hughes SM; Parfitt KD; Abraham WC
    Front Cell Neurosci; 2019; 13():459. PubMed ID: 31680870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.
    Khanna R; Wilson SM; Brittain JM; Weimer J; Sultana R; Butterfield A; Hensley K
    Future Neurol; 2012 Nov; 7(6):749-771. PubMed ID: 23308041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue.
    Martins-de-Souza D; Cassoli JS; Nascimento JM; Hensley K; Guest PC; Pinzon-Velasco AM; Turck CW
    Proteomics Clin Appl; 2015 Oct; 9(9-10):817-31. PubMed ID: 25921334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection against Abeta-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg.
    Mileusnic R; Lancashire C; Clark J; Rose SP
    Behav Pharmacol; 2007 May; 18(3):231-8. PubMed ID: 17426487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by A beta and acts as a cognitive enhancer.
    Mileusnic R; Lancashire CL; Rose SP
    Eur J Neurosci; 2004 Apr; 19(7):1933-8. PubMed ID: 15078567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease.
    Mileusnic R; Lancashire CL; Rose SP
    Ann N Y Acad Sci; 2005 Jun; 1048():149-65. PubMed ID: 16154929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APP is required during an early phase of memory formation.
    Mileusnic R; Lancashire CL; Johnston AN; Rose SP
    Eur J Neurosci; 2000 Dec; 12(12):4487-95. PubMed ID: 11122359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chicks injected with antisera to either S-100 alpha or S-100 beta protein develop amnesia for a passive avoidance task.
    O'Dowd BS; Zhao WQ; Ng KT; Robinson SR
    Neurobiol Learn Mem; 1997 May; 67(3):197-206. PubMed ID: 9159758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The memory enhancing effect of the APP-derived tripeptide Ac-rER is mediated through CRMP2.
    Mileusnic R; Rose SP
    J Neurochem; 2011 Aug; 118(4):616-25. PubMed ID: 21255016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRMP2: functional roles in neural development and therapeutic potential in neurological diseases.
    Ip JP; Fu AK; Ip NY
    Neuroscientist; 2014 Dec; 20(6):589-98. PubMed ID: 24402611
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.